{
    "organizations": [],
    "uuid": "4a9b03b269e21f27a2ed937189ce211df21f62d5",
    "author": "",
    "url": "https://www.reuters.com/article/brief-aceto-subsidiary-rising-pharmaceut/brief-aceto-subsidiary-rising-pharmaceuticals-launches-atenolol-tablets-25mg-50mg-and-100mg-idUSFWN1PX1EB",
    "ord_in_thread": 0,
    "title": "BRIEF-Aceto Subsidiary, Rising Pharmaceuticals, Launches Atenolol Tablets, 25Mg, 50Mg And 100Mg",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 7, 2018 / 7:15 PM / Updated 22 minutes ago BRIEF-Aceto Subsidiary, Rising Pharmaceuticals, Launches Atenolol Tablets, 25Mg, 50Mg And 100Mg Reuters Staff \nFeb 7 (Reuters) - Aceto Corp: \n* ACETO SUBSIDIARY, RISING PHARMACEUTICALS, LAUNCHES ATENOLOL TABLETS, 25MG, 50MG AND 100MG \n* ACETO - UNIT LAUNCHED ATENOLOL TABLETS, 25MG, 50MG AND 100MG, GENERIC VERSION OF TENORMIN FROM ALVOGEN MALTA OPERATIONS Source text for Eikon: Further company coverage:",
    "published": "2018-02-07T21:12:00.000+02:00",
    "crawled": "2018-02-07T21:43:01.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "updated",
        "minute",
        "ago",
        "subsidiary",
        "rising",
        "pharmaceutical",
        "launch",
        "atenolol",
        "tablet",
        "25mg",
        "50mg",
        "100mg",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "aceto",
        "corp",
        "aceto",
        "subsidiary",
        "rising",
        "pharmaceutical",
        "launch",
        "atenolol",
        "tablet",
        "25mg",
        "50mg",
        "100mg",
        "aceto",
        "unit",
        "launched",
        "atenolol",
        "tablet",
        "25mg",
        "50mg",
        "100mg",
        "generic",
        "version",
        "tenormin",
        "alvogen",
        "malta",
        "operation",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}